Anika Therapeutics buy Barrington Research
Start price
03.01.24
/
50%
€20.60
Target price
03.01.25
€26.58
Performance (%)
11.65%
Price
29.08.24
€23.20
Summary
This prediction is currently active. The BUY prediction by Barrington_Research currently has a performance of 11.65%. This prediction currently runs until 03.01.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Anika Therapeutics | 4.505% | 4.505% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€23.40
09.05.24
09.05.24
€34.32
09.05.25
09.05.25
-0.85%
29.08.24
29.08.24
Anika Therapeutics
Start price
Target price
Perf. (%)
€19.70
03.11.23
03.11.23
€26.08
03.11.24
03.11.24
16.75%
29.08.24
29.08.24